Phentermine is an anorectic medication utilized principally for the short-term treatment of obesity as an adjunct to caloric restriction, dietary modifications, and physical exercise. It is formally classified as a psychostimulant due to the fact that it increases mental and physical arousal [via sympathomimetic mechanisms]. Specifically, phentermine facilitates central and peripheral catecholamine release (primarily of …
Phentermine is a natural monoamine alkaloid derivative that was initially approved by the United States FDA in 1959 as an anorectic (appetite suppressant) for the treatment of obesity. It was popularized throughout the early 1970s under the brand name medication “Fastin,” marketed by King Pharmaceuticals. In the late 1990s phentermine was discontinued from pharmaceutical circulation, …
Qsymia is a weight loss drug engineered by the California-based pharmaceutical company Vivus Inc. It was initially approved by the FDA in 2012 for weight reduction among adults with BMIs (body mass indexes) exceeding 30 kg/m² as an adjunct to interventions such as caloric restriction, dietary modification, and regular exercise. Qsymia is also approved for …
Acupuncture is a form of complementary alternative medicine (CAM) in which a practitioner (acupuncturist) stimulates the skin of his/her client transcutaneously [with needles] or transdermally [with electrical pulses or lasers]. According to proponents of traditional Chinese medicine, the precise stimulation of sites across the skin (referred to as “acupuncture points”) modulates the flow of energy …
Data from the CDC (Centers for Disease Control) indicates that approximately 78.6 million adults (34.9%) are clinically obese. Healthcare costs of obesity-related medical conditions such as: cardiovascular disease, cancers, diabetes, and stroke (to name a few) – are thought to exceed $190 billion per year, accounting for over one-fifth of all annual medical expenses in …
According to National Health and Nutrition Examination surveys, over 2 out of 3 adults in the United States are overweight and/or obese. Excessive body weight and/or fat is understood to increase risk for numerous morbidities including: cancer, diabetes, heart disease, hypertension, sleep apnea, and stroke – and that’s just naming a few. Perhaps troubling is …
Naltrexone is a chemical initially synthesized in 1963 and patented thereafter by the pharmaceutical company Endo Laboratories in 1967. It is considered a substituted derivative of oxymorphone in that the tertiary amine methyl-constituent is replaced with an allyl group (specifically an N-cyclopropylmethyl group) – or a longer chain of carbon atoms. It was initially approved …